Favipiravir | Zee News

Advertisement

NewsFavipiravir

Favipiravir News

13 Jun 2021

Odisha government orders probe into 'fake' COVID-19 medicine circulation

The authorities had seized a large quantity of "spurious" Favipiravir tablets in Cuttack on June 10 Nine other drugs allegedly manufactured by the same entity have also been purchased by the Cuttack-based firm

30 Apr 2021

SC to hear plea seeking GST exemption on COVID-19 related drugs

The NGO sought exemption of COVID-19 related drugs, medical equipment, other medical treatment for infection prevention, control measures and supportive care for patients from GST The rate of infection, the positivity rate, as well as the rate of hospitalization for those requiring critical treatment have all increased exponentially with double mutant virus The plea said that section 11 of the CGST Act confers the power of exemption from payment of GST on goods and services to the GST Council

17 Aug 2020

Fusion Health Care launches COVID-19 drug Favipiravir and an immunity booster

Fusion Health Care Pvt Ltd, a leading pharmaceutical company based at Hyderabad, has announced the launch of its Favipiravir drug under the brand name XARAVIR, for the treatment of mild to moderate COVID-19 cases.

21 Jul 2020

Glenmark defends price of its COVID-19 drug favipiravir version

India`s drug regulator had reportedly sent the company a notice on overpricing. Glenmark also denied making any claims that "favipiravir alone" is effective in treatment of mild-to-moderate COVID-19 patients. FabiFlu`s price is significantly lower than versions of favipiravir in other countries, the company added.

11 Jul 2020

Corona drug can't be sold without medical prescription, says Drug Control dept

The Delhi government's Drug Control Department on Friday (July 11, 2020) said that COVID-19 drug namely Remdesivir, Tocilizumab, Favipiravir should only be used for emergency purpose and directed the state drugs controller to keep a check on the selling of these medicines.

Glenmark Pharmaceuticals Ltd

20 Jun 2020

Glenmark gets India's nod for making favipiravir for COVID-19 treatment

The Mumbai-based company said the approval was part of India`s accelerated approval process and the drug was meant for "restricted emergency use," meaning patients must sign their consent before being treated by the drug.

Loading...